VIR Vir Biotechnology PE ratio, current and historical analysis
The current PE ratio of VIR cannot be calculated, as the latest EPS of -$3.83 is negative. The last recorded PE ratio for Vir Biotechnology was 6.51 in December 2022.
VIR PE ratio history
The average historical PE ratio of Vir Biotechnology for the last five years is 35.55. Analyzing the last five years, VIR's PE ratio reached its highest point in the Jun 2020 quarter at 215.63, when the price was $40.97 and the EPS was $0.19. The lowest point was recorded in the Sep 2022 quarter, when it reached 2.21 with a price of $19.28 and an EPS of $8.71.
Vir Biotechnology PE ratio by year
Maximum annual decrease: -36.73% in 2022
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | N/A | N/A | $7.34 | -$3.83 |
| 2023 | N/A | N/A | $10.06 | -$4.59 |
| 2022 | 6.51 | -36.73% | $25.31 | $3.89 |
| 2021 | 10.29 | N/A | $41.87 | $4.07 |
| 2020 | N/A | N/A | $26.78 | -$2.51 |
| 2019 | N/A | N/A | $12.58 | -$5.76 |
| 2018 | N/A | N/A | N/A | -$15.12 |
| 2017 | N/A | N/A | N/A | -$32.45 |
Vir Biotechnology PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | N/A | N/A | $7.34 | -$3.83 |
| Sep 2024 | N/A | N/A | $7.49 | -$3.92 |
| Jun 2024 | N/A | N/A | $8.9 | -$3.58 |
| Mar 2024 | N/A | N/A | $10.13 | -$4.01 |
| Dec 2023 | N/A | N/A | $10.06 | -$4.59 |
| Sep 2023 | N/A | N/A | $9.37 | -$4.5 |
| Jun 2023 | N/A | N/A | $24.53 | -$1.96 |
| Mar 2023 | N/A | N/A | $23.27 | -$1.09 |
| Dec 2022 | 6.51 | 194.57% | $25.31 | $3.89 |
| Sep 2022 | 2.21 | -28.48% | $19.28 | $8.71 |
| Jun 2022 | 3.09 | 11.55% | $25.47 | $8.24 |
| Mar 2022 | 2.77 | -73.08% | $25.72 | $9.3 |
| Dec 2021 | 10.29 | N/A | $41.87 | $4.07 |
| Sep 2021 | N/A | N/A | $43.52 | -$0.84 |
| Jun 2021 | N/A | N/A | $47.28 | -$2.36 |
VIR average PE ratio chart
VIR PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| ORMP Oramed Pharmaceuticals Inc | 21.73 | $96.35M |
| OLMA Olema Pharmaceuticals Inc | N/A | $250.39M |
| OMER Omeros Corp | N/A | $455.49M |
| ONVO Organovo Holdings Inc | N/A | $7.02M |
| ORIC Oric Pharmaceuticals Inc | N/A | $546.91M |
| VIR Vir Biotechnology Inc | N/A | $960M |
Frequently asked questions
What is Vir Biotechnology's PE ratio?
The current price to earnings ratio of VIR cannot be determined, as its EPS of -$3.83 is negative.
What is the 5-year average PE ratio for Vir Biotechnology (VIR)?
Over the last 5 years, the average PE ratio for VIR stock is 35.55.
What is the highest PE ratio for VIR?
Over the last five years, the Jun 2020 quarter recorded the highest quarterly PE ratio at 215.63.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.